Syndax Pharmaceuticals: reports quarterly results
- Form
- 8-K
- Filed
- Importance
- Routine
- Accession
- 0001193125-26-076522
- Reports quarterly results (2.02)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Nurix Therapeutics NRIX public float $808M, May 30, 2025
- Niagen Bioscience NAGE public float $814M, Jun 30, 2025
- Cogent Biosciences COGT public float $773M, Jun 30, 2025
- uniQure QURE public float $765M, Jun 30, 2025
- Phibro Animal Health PAHC public float $764M, Dec 31, 2025